These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 4043227)
1. Involvement of monoaminergic and peptidergic components in cathinone-induced analgesia. Della Bella D; Carenzi A; Frigeni V; Reggiani A; Zambon A Eur J Pharmacol; 1985 Aug; 114(2):231-4. PubMed ID: 4043227 [TBL] [Abstract][Full Text] [Related]
2. Prolonged analgesia induced by cathinone. The role of stress and opioid and nonopioid mechanisms. Nencini P; Ahmed AM; Anania MC; Moscucci M; Paroli E Pharmacology; 1984; 29(5):269-81. PubMed ID: 6093160 [TBL] [Abstract][Full Text] [Related]
3. [Characteristics of acupuncture analgesia, review of the articles on stimulation produced analgesia and morphine like substance (author's transl)]. Watanabe Y; Matsumoto I; Kumazawa T; Ikezono E Masui; 1978 Jul; 27(7):667-75. PubMed ID: 211278 [No Abstract] [Full Text] [Related]
4. The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone. Tulunay FC; Yano I; Takemori AE Eur J Pharmacol; 1976 Feb; 35(2):285-92. PubMed ID: 1248505 [TBL] [Abstract][Full Text] [Related]
5. Differential effects on morphine analgesia and naloxone antagonism by biogenic amine modifiers. Takemori AE; Tulunay FC; Yano I Life Sci; 1975 Jul; 17(1):21-7. PubMed ID: 1143009 [No Abstract] [Full Text] [Related]
6. Characteristics of analgesia induced by noncatecholic phenylethylamine derivatives: possible involvement of endogenous opioid peptides and serotonin in phenylethylamine analog-induced analgesia. Natsuoka Y; Sakuma M; Uruno T; Kubota K Jpn J Pharmacol; 1984 Mar; 34(3):277-87. PubMed ID: 6233440 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat. Ramarao P; Bhargava HN Pharmacology; 1988; 37(1):1-7. PubMed ID: 3420162 [TBL] [Abstract][Full Text] [Related]
8. Endogenous antinociceptive systems: studies on spinal and supraspinal modulating mechanisms with particular reference to monoaminergic and opioid systems. Jensen TS Acta Neurol Scand Suppl; 1986; 108():1-35. PubMed ID: 2873706 [No Abstract] [Full Text] [Related]
9. Mediator mechanisms of cathinone effects on animal behaviour. Babayan EA; Barkov NK; Machula AI Drug Alcohol Depend; 1983 Aug; 12(1):31-5. PubMed ID: 6641497 [TBL] [Abstract][Full Text] [Related]
10. [Monoaminergic modulation of the analgesia induced in rats by (D-Ala2)-met-enkephalinamide (DADA)]. Garzón J; Moratalla R; del Río J Arch Farmacol Toxicol; 1979 Dec; 5(3):177-9. PubMed ID: 546335 [No Abstract] [Full Text] [Related]
11. Interaction between opioid peptides and monoamines in the regulation of gonadotropin secretion in the female rat. Kawagoe S; Hiroi M Asia Oceania J Obstet Gynaecol; 1987 Jun; 13(2):235-41. PubMed ID: 2957986 [No Abstract] [Full Text] [Related]
12. Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective kappa-opioid receptor agonist. Kunihara M; Ohyama M; Nakano M Eur J Pharmacol; 1992 Apr; 214(2-3):111-8. PubMed ID: 1325350 [TBL] [Abstract][Full Text] [Related]
13. Amphetamine-induced analgesia does not involve brain opioids. Drago F; Caccamo G; Continella G; Scapagnini U Eur J Pharmacol; 1984 Jun; 101(3-4):267-9. PubMed ID: 6468501 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of cathinone by caffeine and nikethamide. Schechter MD Pharmacol Biochem Behav; 1989 Jun; 33(2):299-301. PubMed ID: 2813469 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of opioidergic systems in medprotine-induced analgesia in the mouse. Caruso A; Cutuli VM; Candido P; De Bernardis E; Amico-Roxas M Drugs Exp Clin Res; 1994; 20(1):19-27. PubMed ID: 7924891 [TBL] [Abstract][Full Text] [Related]
16. Effect of naloxone on antinociceptive activity of phenoxybenzamine. Elliott HW; Spiehler V; Navarro G Life Sci; 1976 Dec; 19(11):1637-43. PubMed ID: 187885 [No Abstract] [Full Text] [Related]
17. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels. Buxbaum DM; Yarbrough GG; Carter ME J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383 [No Abstract] [Full Text] [Related]
18. Determination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874. Bhalla S; Rapolaviciute V; Gulati A Eur J Pharmacol; 2011 Jan; 651(1-3):109-21. PubMed ID: 21114998 [TBL] [Abstract][Full Text] [Related]
19. Some aspects of the pharmacology of analgesia. Spencer PS J Int Med Res; 1976; 4(2 Suppl):1-14. PubMed ID: 16795 [TBL] [Abstract][Full Text] [Related]